Yi Jun Lu
Corporate Officer/Principal en CANBRIDGE PHARMACEUTICALS INC. .
Perfil
Yi Jun Lu is currently the General Manager at CANbridge Pharmaceuticals Inc. Prior to this, he worked as the Head of Hemophilia & Rare Disease at Takeda (China) Holdings Co. Ltd.
for a brief period in 2020 and as the Head of Hematology at Shire Bioscience (Shanghai) Co., Ltd.
from 2018 to 2019.
Cargos activos de Yi Jun Lu
| Empresas | Cargo | Inicio |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 09/11/2020 |
Antiguos cargos conocidos de Yi Jun Lu.
| Empresas | Cargo | Fin |
|---|---|---|
| Takeda (China) Holdings Co. Ltd. | Corporate Officer/Principal | 01/11/2020 |
| Shire Bioscience (Shanghai) Co., Ltd. | Corporate Officer/Principal | 01/04/2019 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Takeda (China) Holdings Co. Ltd. | |
| Shire Bioscience (Shanghai) Co., Ltd. |
- Bolsa de valores
- Insiders
- Yi Jun Lu
